AIP
SBBP

Ameritas Investment Partners’s Strongbridge Biopharma plc. SBBP Stock Holding History

Ameritas Investment Partners’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,193
Closed -$9K – 3335
2021
Q1 		$9K Hold
3,193
– – ﹤0.01% 2912
2020
Q4 		$8K Hold
3,193
– – ﹤0.01% 2900
2020
Q3 		$7K Hold
3,193
– – ﹤0.01% 2902
2020
Q2 		$12K Hold
3,193
– – ﹤0.01% 2652
2020
Q1 		$6K Hold
3,193
– – ﹤0.01% 2790
2019
Q4 		$7K Hold
3,193
– – ﹤0.01% 2864
2019
Q3 		$8K Hold
3,193
– – ﹤0.01% 2832
2019
Q2 		$10K Buy
+3,193
New +$11.7K ﹤0.01% 2817
2018
Q2 		– Sell
-1,924
Closed -$17K – 3095
2018
Q1 		$17K Hold
1,924
– – ﹤0.01% 2510
2017
Q4 		$14K Hold
1,924
– – ﹤0.01% 2639
2017
Q3 		$12K Hold
1,924
– – ﹤0.01% 2717
2017
Q2 		$14K Buy
+1,924
New +$8.89K ﹤0.01% 2679

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Ameritas Investment Partners's SBBP Position: Q2 2021 in Review

Ameritas Investment Partners sold out of Strongbridge Biopharma plc. (SBBP) in Q2 2021, closing a stake of 3,193 shares — an estimated $9K sold.

Ameritas Investment Partners first reported a position in SBBP in Q2 2017 and held it in 12 quarters. The position peaked at $17K in Q1 2018. 59 funds tracked by Wall St. Rank hold SBBP as of Q2 2021.

  • Ameritas Investment Partners reported no remaining Strongbridge Biopharma plc. position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Partners sold 3,193 Strongbridge Biopharma plc. shares in Q2 2021, an estimated $9K.
  • Ameritas Investment Partners first reported a position in Strongbridge Biopharma plc. in Q2 2017 and held it in 12 quarters.
  • Ameritas Investment Partners's Strongbridge Biopharma plc. position peaked at $17K in Q1 2018.
  • 59 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q2 2021.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.